CoChat

Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder

Open access
Zuckerman, Hannah, Pan, Zihang, Park, Caroline, Brietzke, Elisa, Musial, Natalie, Shariq, Aisha S., Iacobucci, Michelle, Yim, Samantha J., Lui, Leanna M. W., Rong, Carola, McIntyre, Roger S. · 2018 · Frontiers in Psychiatry
Cited by 252

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

Major Depressive Disorder (MDD) is a prevalent, chronic, disabling, and multidimensional mental disorder. Cognitive dysfunction represents a core diagnostic and symptomatic criterion of MDD, and is a principal determinant of functional non-recovery. Cognitive impairment has been observed to persist despite remission of mood symptoms, suggesting dissociability of mood and cognitive symptoms in MDD. Recurrent impairments in several domains including, but not limited to, executive function, learning and memory, processing speed, and attention and concentration, are associated with poor psychosocial and occupational outcomes. Attempts to restore premorbid functioning in individuals with MDD requires regular screenings and assessment of objective and subjective measures of cognition by clinicians. Easily accessible and cost-effective tools such as the THINC-integrated tool (THINC-it) are suitable for use in a busy clinical environment and appear to be promising for routine usage in clinical settings. However, antidepressant treatments targeting specific cognitive domains in MDD have been insufficiently studied. While select antidepressants, e.g., vortioxetine, have been demonstrated to have direct and independent pro-cognitive effects in adults with MDD, research on additional agents remains nascent. A comprehensive clinical approach to cognitive impairments in MDD is required. The current narrative review aims to delineate the importance and relevance of cognitive dysfunction as a symptomatic target for prevention and treatment in the phenomenology of MDD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fpsyt.2018.00655

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Research works printed but not linked: 40

  1. 2017, Depression and Other Common Mental Disorders Global Health
  2. Jacobs, 2009, PMH31 measuring the economic burden of depression using patient records, Value Health, 12, A356, 10.1016/S1098-3015(10)74750-1 · doi:10.1016/s1098-3015(10)74750-1
  3. Lépine, 2011, The increasing burden of depression, Neuropsychiatric Dis Treatmen, 7, 3, 10.2147/NDT.S19617 · DOI · Paper page
  4. Zimmerman, 2006, Discordance between self-reported symptom severity and psychosocial functioning ratings in depressed outpatients: implications for how remission from depression should be defined, Psychiatry Res, 141, 185, 10.1016/j.psychres.2005.05.016 · DOI
  5. Stedman, 2012, Stedman's Medical Dictionary for the Health Professions and Nursing.
  6. 2013, In Diagnostic and Statistical Manual of Mental Disorders
  7. Cserjési, 2009, Altered executive function in obesity. exploration of the role of affective states on cognitive abilities, Appetite., 52, 535, 10.1016/j.appet.2009.01.003 · DOI · Paper page
  8. Larochette, 2011, Additive Neurocognitive Deficits in Adults with attention-deficit/hyperactivity disorder and depressive symptoms, Arch Clin Neuropsychol., 26, 385, 10.1093/arclin/acr033 · DOI
  9. Mansur, 2014, Diabetes mellitus and disturbances in brain connectivity: abidirectional relationship?, Neuromol Med., 16, 658, 10.1007/s12017-014-8316-8 · DOI
  10. Thomas, 2009, A comparison of neurocognitive impairment in younger and older adults with major depression, Psychol Med., 39, 725, 10.1017/S0033291708004042 · DOI · Paper page
  11. Gildengers, 2012, Cognition in older adults with bipolar disorder versus major depressive disorder, Bipolar Disord., 14, 198, 10.1111/j.1399-5618.2012.00995.x · DOI · Paper page
  12. Withall, 2010, A longitudinal study of cognitive function in melancholic and non-melancholic subtypes of major depressive disorder, J Affect Disord., 123, 150, 10.1016/j.jad.2009.07.012 · DOI
  13. Pan, 2017, Pharmacological treatment of cognitive symptoms in major depressive disorder, CNS Neurol Disord. - Drug Targets, 16, 1, 10.2174/1871527316666170919115100 · DOI
  14. Lemos-Miller, 2006, Depression and ethnicity as intermediary variables among dissociation, trauma-related cognitions, and PTSD Symptomatology in Youths, J Nervous Mental Dis., 194, 584, 10.1097/01.nmd.0000230407.12687.ba · DOI · Paper page
  15. Park, 2018, Predicting antidepressant response using early changes in cognition: a systematic review, Behav Brain Res., 353, 154, 10.1016/j.bbr.2018.07.011 · DOI
  16. McIntyre, 2015, The impact of cognitive impairment on perceived workforce performance: results from the international mood disorders collaborative project, Comprehens Psychiatry, 56, 279, 10.1016/j.comppsych.2014.08.051 · DOI
  17. Ott, 2016, Screening for cognitive dysfunction in unipolar depression: validation and evaluation of objective and subjective tools, J Affect Disord., 190, 607, 10.1016/j.jad.2015.10.059 · DOI · Paper page
  18. Mackin, 2013, The effect of subsyndromal symptoms of depression and white matter lesions on disability for individuals with mild cognitive impairment, Am J Geriat Psychiatry, 21, 906, 10.1016/j.jagp.2013.01.021 · DOI · Paper page
  19. Lee, 2013, Cognitive remediation improves memory and psychosocial functioning in first-episode psychiatric out-patients, Psychol Med., 43, 1161, 10.1017/S0033291712002127 · DOI · Paper page
  20. Naismith, 2011, Enhancing memory in late-life depression: the effects of a combined psychoeducation and cognitive training program, Am J Geriatr Psychiatry, 19, 240, 10.1097/JGP.0b013e3181dba587 · DOI
  21. Lemogne, 2012, Medial prefrontal cortex and the self in major depression, J Affect Disord., 136, e1, 10.1016/j.jad.2010.11.034 · DOI · Paper page
  22. Yoshimura, 2010, Rostral anterior cingulate cortex activity mediates the relationship between the depressive symptoms and the medial prefrontal cortex activity, J Affect Disord., 122, 76, 10.1016/j.jad.2009.06.017 · DOI · Paper page
  23. Yoshimura, 2017, Cognitive behavioral therapy changes functional connectivity between medial prefrontal and anterior cingulate cortices, J Affect Disord., 208, 610, 10.1016/J.JAD.2016.10.017 · DOI
  24. Semkovska, 2010, Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis, 68, 568, 10.1016/j.biopsych.2010.06.009 · DOI · Paper page
  25. Miskowiak, 2014, “Hot” cognition in major depressive disorder: a systematic review, CNS Neurol Disord Drug Targets, 13, 1787, 10.2174/1871527313666141130205713 · DOI · Paper page
  26. Miskowiak, 2007, Single dose antidepressant administration modulates the neural processing of self-referent personality trait words, NeuroImage, 37, 904, 10.1016/j.neuroimage.2007.05.036 · DOI
  27. Nathan, 2014, Increasing pharmacological knowledge about human neurological and psychiatric disorders through functional neuroimaging and its application in drug discovery, Curr Opin Pharmacol., 14, 54, 10.1016/j.coph.2013.11.009 · DOI
  28. Rasmussen, 2011, Some considerations in choosing electroconvulsive therapy versus transcranial magnetic stimulation for depression, J ECT, 27, 51, 10.1097/YCT.0b013e3181da84c6 · DOI · Paper page
  29. Ressler, 2001, Role of norepinephrine in the pathophysiology of neuropsychiatric disorders, CNS Spectrums., 6, 663, 10.1017/S1092852900001358 · DOI · Paper page
  30. FDA Updates Trintellix® (vortioxetine) Label to Include Data Showing Improvement in Processing Speed, an Important Aspect of Cognitive Function in acute Major Depressive Disorder (MDD).2018
  31. Rowland, 2005, Selective cognitive impairments associated with NMDA receptor blockade in humans, Neuropsychopharmacology, 30, 633, 10.1038/sj.npp.1300642 · DOI · Paper page
  32. Krystal, 1999, Interactive effects of subanesthetic ketamine and haloperidol in healthy humans, Psychopharmacology, 145, 193, 10.1007/s002130051049 · DOI · Paper page
  33. Morgan, 2004, Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers, Neuropsychopharmacology., 29, 208, 10.1038/sj.npp.1300342 · DOI · Paper page
  34. Price, 2014, Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression, Depress Anxiety, 31, 335, 10.1002/da.22253 · DOI · Paper page
  35. Bunn, 2013, Erythropoietin, Cold Spring Harbor Perspect Med., 3, a011619, 10.1101/cshperspect.a011619 · DOI · Paper page
  36. Miskowiak, 2012, Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression, Psychopharmacology, 219, 687, 10.1007/s00213-011-2511-1 · DOI
  37. Sun, 2018, Exercise for cognitive symptoms in depression: a systematic review of interventional studies, Can J Psychiatry, 63, 115, 10.1177/0706743717738493 · DOI · Paper page
  38. Reger, 2008, Intranasal insulin improves cognition and modulates -amyloid in early AD, Neurology., 70, 440, 10.1212/01.WNL.0000265401.62434.36 · DOI · Paper page
  39. Craft, 2012, Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial, Archi Neurol., 69, 29, 10.1001/archneurol.2011.233 · DOI · Paper page
  40. Cha, 2017, A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder, J Affect Disord., 210, 57, 10.1016/j.jad.2016.12.006 · DOI

Cited by

Metadata

Authors
Zuckerman, H., Pan, Z., Park, C., Brietzke, E., Musial, N., Shariq, A. S., Iacobucci, M., Yim, S. J., Lui, L. M. W., Rong, C., & McIntyre, R. S.
Venue
Frontiers in Psychiatry
Published
2018-12-04
Volume
9
Pages
655-655
ISSN
1664-0640 (ISSN-L)
OpenAlex
W2902778000
Cited by
252
References
53
FWCI
11.50
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.